Dr. Michaela M Liedtke, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
She has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Hannover Medical School | Medical Degree | Medical | Not Specified |
| Medizinische Hochschule Hannover | Medical Degree | 1994 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Albert Einstein College of Medicine | 2002 | |
| Residency - Albert Einstein College of Medicine Affiliated Hospitals | 2002 | |
| Fellowship - Stanford University Medical Center CA | 2005 | |
| Fellowship - Memorial Sloan-Kettering Cancer Center NY | 2004 | |
| Fellowship - Stanford University Medical Center CA | 2005 | |
| Fellowship - Memorial Sloan-Kettering Cancer Center NY | 2004 | |
| Fellowship - Stanford University Medical Center, Stanford Ca - Bariatric Surgery | 2005 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 2006 |
Sub-Specialty: Hematology | Internal Medicine | 2005 |
| Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | 2006 |
| Internal medicine Sub-Specialty: Hematology | Internal Medicine | 2005 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine | Stanford University Medical Center | Present |
| Member | Leukemia Committee, Southwest | Present |
| Member | Stanford Amyloid Center | 2010 - 2014 |
| Member | Oncology Group | 2011 - 2014 |
| Distinction | Institution | Year |
|---|---|---|
| Doris Duke Foundation | Translational Research Award | 2004 |
| ASCO | Young Investigator Award | 2008 |
| Research grant, Hope Street Kids Foundation | 2006 | |
| Methods in Clinical Cancer Research Scholar, ASCO/AACR | 2005 | |
| Lymphoma Research Foundation | Fellowship Award | 2004 |
| Stanford Department of Medicine | Translational Research Award | 2011 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Leukemia & lymphoma | A single-center experience of the tionwide daunorubicin shortage | 2013 |
| Other Publication | Haematologica | Lelidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain | 2013 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | AG10 inhibits amyloidogenesis | 2013 |
| Other Publication | BRITISH JOURL OF HAEMATOLOGY | The prognostic value of diagnosing concurrent multiple myeloma | 2013 |
| Other Publication | Haematologica | Sequential azacitidine plus lelidomide combition | 2013 |
| Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines | 2013 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for | 2012 |
| Other Publication | JOURL OF HEART AND LUNG TRANSPLANTATION | Heart transplantation and cardiac amyloidosis: Approach to screening and novel magement strategies | 2012 |
| Other Publication | Hematology (Amsterdam, Netherlands) | Hemophagocytic lymphohistiocytosis in pregncy: A case report and review of treatment options. | |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
| Other Publication | AMERICAN JOURL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and magement. | 2010 |
| Other Publication | ANLS OF ONCOLOGY | Surveillance imaging during remission identifies a group of patients with more favorable aggressive | 2006 |
| Other Publication | ONCOGENE | Regulation of Bcr-Abl-induced SAP kise activity | 1998 |
| Other Publication | Immunologic research | Effects of serum and plasma matrices on multiplex immunoassays. | 2014 |
| Other Publication | HEART RHYTHM | Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis | 2014 |
| Other Publication | Leukemia & lymphoma | A single-center experience of the nationwide daunorubicin shortage | 2013 |
| Other Publication | Haematologica | Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light | 2013 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | AG10 inhibits amyloidogenesis | 2013 |
| Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | The prognostic value of diagnosing concurrent multiple myeloma | 2013 |
| Other Publication | Haematologica | Sequential azacitidine plus lenalidomide combination | 2013 |
| Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma, Version 1.2013 Featured Updates to the NCCN Guidelines | 2013 |
| Other Publication | Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C. | Amrubicin, a Novel Investigational Anthracycline | |
| Other Publication | Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med | A Phase I/II Study of Bortezomib | |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
| Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide | 2012 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | More Than a Frog in the Throat A Case Series and Review of Localized Laryngeal Amyloidosis | 2012 |
| Other Publication | JOURNAL OF HEART AND LUNG TRANSPLANTATION | Heart transplantation and cardiac amyloidosis | 2012 |
| Other Publication | Hematology (Amsterdam, Netherlands) | Hemophagocytic lymphohistiocytosis in pregnancy: A case report and review of treatment options. | |
| Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B | 2012 |
| Other Publication | GENOME BIOLOGY | The Transcription Factor Encyclopedia | 2012 |
| Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
| Other Publication | Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., | Temozolomide In Acute Myeloid Leukemia | 2010 |
| Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
| Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and management. | 2010 |
| Other Publication | BLOOD | Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential | 2010 |
| Other Publication | BLOOD | Therapeutic targeting of MLL | 2009 |
| Other Publication | LEUKEMIA & LYMPHOMA | Reversible high-output cardiac failure, an unusual marker of disease status in multiple myeloma | 2008 |
| Other Publication | ANNALS OF ONCOLOGY | Surveillance imaging during remission identifies a group of patients with more favorable aggressive | 2006 |
| Other Publication | ONCOGENE | Regulation of Bcr-Abl-induced SAP kinase activity | 1998 |
| Other Publication | BIOCHEMISTRY | A SITE-DIRECTED MUTAGENESIS STUDY TO IDENTIFY AMINO | 1992 |
Dr. Michaela M Liedtke, MD has not yet indicated the hospitals that she is affiliated with.
Accepts New Patients: Yes
Dr. Michaela M Liedtke, MD has not yet listed the medications that she commonly prescribes.
Dr. Michaela M Liedtke, MD has not yet added any information about her practice's billing policies and payment options.
